Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma
- 5 May 2011
- journal article
- Published by American Society of Hematology in Blood
- Vol. 117 (18), 4726-4735
- https://doi.org/10.1182/blood-2010-12-323238
Abstract
We investigated age-related EBV+ B-cell lymphoproliferations in the Western population. The clinical features, histology, immunophenotype, EBV-encoded RNA in situ hybridization, and clonality by PCR of T-cell receptor gamma and immunoglobulin genes were categorized in 122 EBV+ lesions as follows: (1) reactive lymphoid hyperplasia; (2) polymorphic extranodal or (3) polymorphic nodal lymphoproliferative disease (LPD); and (4) diffuse large B-cell lymphoma (DLBCL). Interphase FISH for IG and PAX5 gene rearrangements was performed on 17 cases of DLBCL. The overall median age was 75 years (range, 45-101 years; 67 men, 55 women), and 67, 79, 73, and 77 years, respectively, for groups 1 through 4. Sixteen of 21 cases of polymorphic extranodal LPD were classified as EBV+ mucocutaneous ulcer. PCR for immunoglobulin genes was polyclonal in reactive lymphoid hyperplasia (84%) and monoclonal in 33%, 63%, and 56% of polymorphic extranodal and nodal LPD cases and DLBCL, respectively. All groups showed restricted/clonal T-cell receptor responses (27%-70%). By FISH, 19% of DLBCLs showed IGH@ rearrangements, but PAX5 was unaffected. Disease-specific 5-year survival was 100%, 93%, 57%, and 25% for groups 1-4, respectively, and 100% for patients with EBV+ mucocutaneous ulcer. Disease volume was predictive of therapy response (P = .0002), and pathologic subtype was predictive of overall outcome (P = .001). Age-related EBV+ B-cell LPD encompasses a wider disease spectrum than previously recognized and includes both reactive and neoplastic conditions. Reduction in the T-cell repertoire may contribute to decreased immune surveillance.Keywords
This publication has 41 references indexed in Scilit:
- EBV Positive Mucocutaneous Ulcer—A Study of 26 Cases Associated With Various Sources of ImmunosuppressionThe American Journal of Surgical Pathology, 2010
- Epstein–Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8–9 September 2008Annals Of Oncology, 2009
- B‐cell diversity decreases in old age and is correlated with poor health statusAging Cell, 2009
- Contribution of the Epstein–Barr virus to the molecular pathogenesis of Hodgkin lymphomaJournal of Clinical Pathology, 2007
- Immunity and ageing in man: Annual review 2006/2007Experimental Gerontology, 2007
- Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trialBlood, 2007
- FISH Analysis for the Detection of Lymphoma-Associated Chromosomal Abnormalities in Routine Paraffin-Embedded TissueThe Journal of Molecular Diagnostics, 2006
- Genital Ulcers as Initial Manifestation of Epstein-Barr Virus Infection: Two New Cases and a Review of the LiteraturePublished by Medical Journals Sweden AB ,2006
- Biology and Treatment of Epstein-Barr Virus–Associated Non-Hodgkin LymphomasHematology-American Society Hematology Education Program, 2005
- Characteristics of Hodgkin's Lymphoma after Infectious MononucleosisNew England Journal of Medicine, 2003